Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	628	323	88	174	242	64
Market Cap Growth	233.55%	269.38%	-49.64%	-28.05%	276.02%	-
Enterprise Value	535	282	17	50	221	60
Last Close Price	4.01	2.31	0.75	1.60	3.58	3.28
PE Ratio	-	-10.34	-2.14	-6.89	-1.48	-1.68
PS Ratio	549.20	32.34	-	4.77	-	-
PB Ratio	7.83	6.40	1.70	1.98	-16.14	1.60
P/FCF Ratio	-27.43	-15.30	-1.79	-30.11	-8.52	-1.40
P/OCF Ratio	-27.43	-15.30	-1.79	-33.18	-8.53	-1.40
EV/Sales Ratio	534.69	28.17	-	1.38	-	-
EV/EBITDA Ratio	-13.58	-10.60	-0.32	-2.41	-6.13	-1.60
EV/EBIT Ratio	-13.36	-10.38	-0.31	-2.40	-5.87	-1.54
EV/FCF Ratio	-25.30	-13.33	-0.34	-8.70	-7.78	-1.31
Debt / Equity Ratio	0.08	0.12	0.30	0.19	-1.20	0.81
Debt / FCF Ratio	-0.31	-0.28	-0.31	-2.90	-0.63	-0.71
Asset Turnover	0.01	0.14	-	0.39	-	-
Quick Ratio	5.78	6.38	2.89	7.66	3.23	0.94
Current Ratio	6.07	6.72	3.09	7.92	3.47	1.02
Return on Equity (ROE)	-48.47%	-57.81%	-53.63%	34.85%	-1294.27%	-95.43%
Return on Assets (ROA)	-23.86%	-23.57%	-28.67%	-13.82%	-31.43%	-31.85%
Return on Capital (ROIC)	-27.87%	-27.52%	-34.13%	-24.29%	-62.09%	-38.57%
Earnings Yield	-5.98%	-9.11%	-48.22%	7.32%	-67.72%	-54.22%
FCF Yield	-3.25%	-6.53%	-55.78%	-3.32%	-11.74%	-71.51%
Buyback Yield / Dilution	-12.05%	-9.33%	-8.63%	-63.82%	-279.04%	-25.69%
Total Shareholder Return	-12.05%	-9.33%	-8.63%	-63.82%	-279.04%	-25.69%

Source: S&P Capital IQ. Standard template. Financial Sources.